Sort
30,917 grants matching “tumor microenvironment”
Effects of chronic pubertal stressors on mammary gland biology and cancer risk
$462,106Matthew J Brady · University Of Chicago · R01 · FY2025 · CA
Investigating novel targets for topical immunoprevention of keratinocytic skin cancer
$462,092Sally E Dickinson · University Of Arizona · UG3 · FY2025 · CA
Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics
$462,077Joerg Lahann · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1
$462,010Rong Li · George Washington University · R01 · FY2021 · CA
Improving efficacy of radioiodine treatment of thyroid cancer
$461,989James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Improving efficacy of radioiodine treatment of thyroid cancer
$461,989James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Project 3: Adaptive immunity to MCPyV in Merkel cell carcinoma
$461,978David M Koelle · University Of Washington · P01 · FY2019 · CA
Hyperpolarized 13C Metabolic Imaging of Tumorigenesis in the Liver
$461,844Kelvin L Billingsley · Loyola University Of Chicago · R15 · FY2023 · CA
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
$461,824Taha Merghoub · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Negative regulation of myeloid-derived suppressive cells in cancer
$461,819Yulia Nefedova · Wistar Institute · R01 · FY2022 · CA
Acid-Sensitive Glioblastoma Prodrugs Derived from Ophiobolin A
$461,764Alexander Kornienko · Texas State University · R15 · FY2019 · CA
Cancer Center Support Grant
$461,750Gerold Bepler · Wayne State University · P30 · FY2016 · CA
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
$461,706Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
BCL11B activation as an approach for enhancing the efficacy of immunotherapy
$461,674Chintan Parekh · Children'S Hospital Of Los Angeles · R01 · FY2022 · AI
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion
$461,646Xiang Zhang · Baylor College Of Medicine · R01 · FY2024 · CA
3-Dimensional Retinal Organoid Platform for the Study of Retinoblastoma
$461,601Daniel Pelaez · University Of Miami School Of Medicine · R01 · FY2023 · CA
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
$461,562Matthew J Lazzara · University Of Virginia · U01 · FY2021 · CA
Modulation of tumor inflammatory factor for immune therapy
$461,550Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2017 · CA
Interplay between tumor and microenvironment in bone metastasis
$461,537Paul B Fisher · Virginia Commonwealth University · R01 · FY2022 · CA
Interplay between tumor and microenvironment in bone metastasis
$461,537Paul B Fisher · Virginia Commonwealth University · R01 · FY2023 · CA
A novel preclinical model of spontaneous metastasis
$461,518Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Regulation of metastatic progression by an endothelial-derived factor
$461,474Sohail F. Tavazoie · Rockefeller University · R01 · FY2022 · CA
Computational Methods for Identifying Non-coding Cancer Drivers
$461,451Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
$461,446David G Denardo · Washington University · U01 · FY2025 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$461,363Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA